Chapter 105 Cutaneous Manifestations of Drug Abuse

Haley Naik & Richard Allen Johnson

12. Moliterno DJ et al: Influence of intranasal cocaine on plasma constituents associated with endogenous thrombosis and thrombolysis. Am J Med 96(6):492-496, 1994 13. Muniz AE, Evans T: Acute gastrointestinal manifestations associated with use of crack. Am J Emerg Med 19(1):61-63, 2001 14. Strickland TL et al: Cerebral perfusion and neuropsychological consequences of chronic cocaine use. J Neuropsychiatry Clin Neurosci 5(4):419-427, 1993 15. Vongpatanasin W et al: Cocaine stimulates the human cardiovascular system via a central mechanism of action. Circulation 100(5):497-502, 1999 16. Cregler LL, Mark H: Medical complications of cocaine abuse. N Engl J Med 315(23):1495-1500, 1986 17. Goldfrank LR, Hoffman RS: The cardiovascular effects of cocaine. Ann Emerg Med 20(2):165-175, 1991 18. Spivey WH, Euerle B: Neurologic complications of cocaine abuse. Ann Emerg Med 19(12):1422-1428, 1990 19. Hoeger PH, Haupt G, Hoelzle E: Acute multifocal skin necrosis: Synergism between invasive streptococcal infection and cocaine-induced tissue ischaemia? Acta Derm Venereol 76(3):239-241, 1996 20. Abidin MR et al: Injection of illicit drugs into the granulation tissue of chronic ulcers. Ann Plast Surg 24(3):268-270, 1990 21. Kircik LH, Wirth P, Pincus SH: Scars on the legs. Cutaneous fibrosis resulting from intracutaneous injection of cocaine. Arch Dermatol 128(12):1644, 1647, 1992 22. Feeney CM, Briggs S: Crack hands: A dermatologic effect of smoking crack cocaine. Cutis 50(3):193194, 1992 23. Payne-James JJ, Munro MH, Rowland Payne CM: Pseudosclerodermatous triad of perniosis, pulp atrophy and parrot-beaked clawing of the nailsA newly recognized syndrome of chronic crack cocaine use. J Forensic Leg Med 14(2):65-71, 2007 24. Woodburn KR, Murie JA: Vascular complications of injecting drug misuse. Br J Surg 83(10):13291334, 1996 25. Maxwell TM, Olcott CT, Blaisdell FW: Vascular complications of drug abuse. Arch Surg 105(6):875-882, 1972

REFERENCES
1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders IV-TR, 4th edition. Washington DC, American Psychiatric Press, 2000 2. Abuse NIoD: 2010, http://www.drugabuse.gov, accessed Jun 15, 2010 3. Nations U: World Drug Report, 2004, http://www. unis.unvienna.org/unis/pressrels/2004/unisnar849.html, accessed Apr 1, 2010 4. Services USDoHaH: National Survey on Drug Use and Health, 2008, http://www.oas.samhsa.gov/ NSDUHlatest.htm, accessed Apr 1, 2010 5. Tsuang MT et al: The harvard twin study of substance abuse: What we have learned. Harv Rev Psychiatry 9(6):267-279, 2001 6. Bibb JA et al: Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5. Nature 410(6826):376-380, 2001 7. Kalivas PW, Volkow ND: The neural basis of addiction: A pathology of motivation and choice. Am J Psychiatry 162(8):1403-1413, 2005 8. Michigan UO. Monitoring the Future, 2010, http:// www.monitoringthefuture.org/, accessed Jun 10, 2010 9. Konzen JP, Levine SR, Garcia JH: Vasospasm and thrombus formation as possible mechanisms of stroke related to alkaloidal cocaine. Stroke 26(6):1114-1118, 1995 10. Lange RA, Hillis LD: Cardiovascular complications of cocaine use. N Engl J Med 345(5):351-358, 2001 11. Merkel PA et al: Cocaine-associated cerebral vasculitis. Semin Arthritis Rheum 25(3):172-183, 1995

608

Chapter 105:

Cutaneous Manifestations of Drug Abuse

26. Saleem TM, et al: Renal infarction: A rare complication of cocaine abuse. Am J Emerg Med 19(6):528-529, 2001 27. Novielli KD, Chambers CV: Splenic infarction after cocaine use. Ann Intern Med 114(3):251-252, 1991 28. Bellows CF, Raafat AM: The surgical abdomen associated with cocaine abuse. J Emerg Med 23(4):383-386, 2002 29. Ellis CN, McAlexander WW: Enterocolitis associated with cocaine use. Dis Colon Rectum 48(12):2313-2316, 2005 30. Friedman DR, Wolfsthal SD: Cocaine-induced pseudovasculitis. Mayo Clin Proc 80(5):671-673, 2005 31. Hofbauer GF, Hafner J, Trueb RM: Urticarial vasculitis following cocaine use. Br J Dermatol 141(3):600-601, 1999 32. Orriols R et al: Cocaine-induced Churg-Strauss vasculitis. Eur Respir J 9(1):175-177, 1996 33. Balbir-Gurman A, Braun-Moscovici Y, Nahir AM: Cocaine-Induced raynauds phenomenon and ischaemic finger necrosis. Clin Rheumatol 20(5):376-378, 2001 34. Noel B: Cocaine and arsenic-induced Raynauds phenomenon. Clin Rheumatol 21(4):343-344, 2002 35. Brust JC: Vasculitis owing to substance abuse. Neurol Clin 15(4):945-957, 1997 36. Chevalier X et al: Schoenlein-Henoch purpura with necrotizing vasculitis after cocaine snorting. Clin Nephrol 43(5):348-349, 1995 37. Bozkurt AK: The role of cocaine in the etiology of Buerger disease is questionable. Arch Intern Med 161(3):486, 2001 38. Marder VJ, Mellinghoff IK: Cocaine and Buerger disease: Is there a pathogenetic association? Arch Intern Med 160(13):2057-2060, 2000 39. Rhodes T, et al: Crack-heroin speedball injection and its implications for vein care: Qualitative study. Addiction 102(11):1782-1790, 2007 40. Ciccarone D, Bourgois P: Explaining the geographical variation of HIV among injection drug users in the United States. Subst Use Misuse 38(14):2049-2063, 2003 41. Tyndall MW et al: Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. AIDS 17(6):887-893, 2003 42. Blanksma CJ, Brand HS: Cocaine abuse: Orofacial manifestations and implications for dental treatment. Int Dent J 55(6):365-369, 2005

43. Kapila YL, Kashani H: Cocaine-associated rapid gingival recession and dental erosion. A case report. J Periodontol 68(5):485-488, 1997 44. Faruque S, et al: Crack cocaine smoking and oral sores in three inner-city neighborhoods. J Acquir Immune Defic Syndr Hum Retrovirol 13(1):87-92, 1996 45. Sastry RC, Lee D, Har-El G: Palate perforation from cocaine abuse. Otolaryngol Head Neck Surg 116(4):565-566, 1997 46. Mattson-Gates G, Jabs AD, Hugo NE: Perforation of the hard palate associated with cocaine abuse. Ann Plast Surg 26(5):466-468, 1991 47. Mari A, et al: Nasal cocaine abuse and centrofacial destructive process: Report of three cases including treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 93(4):435-439, 2002 48. Deutsch HL, Millard DR Jr: A new cocaine abuse complex. Involvement of nose, septum, palate, and pharynx. Arch Otolaryngol Head Neck Surg 115(2):235-237, 1989 49. Villa PD: Midfacial complications of prolonged cocaine snorting. J Can Dent Assoc 65(4):218-223, 1999 50. Osborne R, et al: Adult supraglottitis subsequent to smoking crack cocaine. Ear Nose Throat J 82(1):53-55, 2003 51. Sachs R, Zagelbaum BM, Hersh PS: Corneal complications associated with the use of crack cocaine. Ophthalmology 100(2):187-191, 1993 52. Schwartz RH, et al: Nasal symptoms associated with cocaine abuse during adolescence. Arch Otolaryngol Head Neck Surg 115(1):63-64, 1989 53. Snyderman C et al: Crack cocaine burns of the larynx. Arch Otolaryngol Head Neck Surg 117(7):792795, 1991 54. Lu LK, High WA: Acute generalized exanthematous pustulosis caused by illicit street drugs? Arch Dermatol 143(3):430-431, 2007 55. Hofbauer GF, Burg G, Nestle FO: Cocaine-related Stevens-Johnson syndrome. Dermatology 201(3):258-260, 2000 56. Wolgin DL, Hertz JM: Effects of acute and chronic cocaine on milk intake, body weight, and activity in bottle- and cannula-fed rats. Behav Pharmacol 6(7):746-753, 1995 57. Brady KT et al: Cocaine-induced psychosis. J Clin Psychiatry 52(12):509-512, 1991 58. Zhu NY, Legatt DF, Turner AR: Agranulocytosis after consumption of cocaine adulterated with levamisole. Ann Intern Med 150(4):287-289, 2009

Copyright McGraw-Hill Companies, Inc. All rights reserved.

Chapter 105:

Cutaneous Manifestations of Drug Abuse

609

59. Kinzie E. Levamisole found in patients using cocaine. Ann Emerg Med 53(4):546-547, 2009 60. Darke S, Ross J, Kaye S: Physical injecting sites among injecting drug users in Sydney, Australia. Drug Alcohol Depend 62(1):77-82, 2001 61. Rathod NH, de Alarcon R, Thomson IG: Signs of heroin usage detected by drug users and their parents. Lancet 2(7531):1411-1414, 1967 62. Young AW Jr, Rosenberg FR: Cutaneous stigmas of heroin addiction. Arch Dermatol 104(1):80-86, 1971 63. Shuster MM, Lewin ML: Needle tracks in narcotic addicts. N Y State J Med 68(24):3129-3134, 1968 64. Redmond WJ. Heroin adulterants and skin disease. Arch Dermatol 115(1):111, 1979 65. Neviaser RJ, Butterfield WC, Wieche DR: The puffy hand of drug addiction: A study of the pathogenesis. J Bone Joint Surg Am 54(3):629-633, 1972 66. Heng MC, Feinberg M, Haberfelde G: Erythematous cutaneous nodules caused by adulterated cocaine. J Am Acad Dermatol 21(3 Pt 1):570-572, 1989 67. Rosen VJ. Cutaneous manifestations of drug abuse by parenteral injections. Am J Dermatopathol 7(1):79-83, 1985 68. Passaro DJ, et al: Wound botulism associated with black tar heroin among injecting drug users. JAMA 279(11):859-863, 1998 69. Callahan TE, Schecter WP, Horn JK: Necrotizing soft tissue infection masquerading as cutaneous abcess following illicit drug injection. Arch Surg 133(8):812-817; discussion 817-819, 1998 70. Chen JL, Fullerton KE, Flynn NM: Necrotizing fasciitis associated with injection drug use. Clin Infect Dis 33(1):6-15, 2001 71. Haverkos HW, Lange WR: From the Alcohol, Drug Abuse, and Mental Health Administration. Serious infections other than human immunodeficiency virus among intravenous drug abusers. J Infect Dis 161(5):894-902, 1990 72. Dunne JH, Johnson WC: Necrotizing skin lesions in heroin addicts. Arch Dermatol 105(4):544-547, 1972 73. Mitchell PA, Pons PT: Wound botulism associated with black tar heroin and lower extremity cellulitis. J Emerg Med 20(4):371-375, 2001 74. Abdulla A, Yee L: The clinical spectrum of Clostridium sordellii bacteraemia: Two case reports and a review of the literature. J Clin Pathol 53(9):709712, 2000

75. McGregor JA et al: Maternal deaths associated with Clostridium sordellii infection. Am J Obstet Gynecol 161(4):987-995, 1989 76. Sinave C et al: Toxic shock syndrome due to Clostridium sordellii: A dramatic postpartum and postabortion disease. Clin Infect Dis 35(11):14411443, 2002 77. Tuazon CU, Hill R, Sheagren JN: Microbiologic study of street heroin and injection paraphernalia. J Infect Dis 129(3):327-329, 1974 78. Bisbe J et al: Disseminated candidiasis in addicts who use brown heroin: Report of 83 cases and review. Clin Infect Dis 15(6):910-923, 1992 79. Perlman DC et al: Shotgunning as an illicit drug smoking practice. J Subst Abuse Treat 14(1):3-9, 1997 80. Weidman AI, Fellner MJ: Cutaneous manifestations of heroin and other addictive drugs. Study and analysis. N Y State J Med 71(22):2643-2646, 1971 81. Llibre LM, et al: [Lyells syndrome induced by heroin contaminants]. Med Clin (Barc) 94(20):799, 1990 82. Neugarten J et al: Amyloidosis in subcutaneous heroin abusers (skin poppers amyloidosis). Am J Med 81(4):635-640, 1986 83. Tossmann P, Boldt S, Tensil MD: The use of drugs within the techno party scene in European metropolitan cities. Eur Addict Res 7(1):2-23, 2001 84. Sulzer D et al: Mechanisms of neurotransmitter release by amphetamines: A review. Prog Neurobiol 75(6):406-433, 2005 85. Klasser GD, Epstein J: Methamphetamine and its impact on dental care. J Can Dent Assoc 71(10):759-762, 2005 86. Cook HA, et al: Heterosexual transmission of community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis 44(3):410413, 2007 87. Hamamoto DT, Rhodus NL: Methamphetamine abuse and dentistry. Oral Dis 15(1):27-37, 2009 88. Kratofil PH, Baberg HT, Dimsdale JE: Self-mutilation and severe self-injurious behavior associated with amphetamine psychosis. Gen Hosp Psychiatry 18(2):117-120, 1996 89. Sanchez-Morillas L et al: Systemic dermatitis due to tetrazepam. J Investig Allergol Clin Immunol 18(5):404-406, 2008 90. Thomas E et al: Acute generalized exanthematous pustulosis due to tetrazepam. J Investig Allergol Clin Immunol 18(2):119-122, 2008

Copyright McGraw-Hill Companies, Inc. All rights reserved.

610

Chapter 105:

Cutaneous Manifestations of Drug Abuse

91. Amichai B, Grunwald MH: Erythema multiforme due to clonazepamsupportive evidence from the macrophage migration inhibition factor test. Clin Exp Dermatol 23(5):206-207, 1998 92. Kiraly CL et al: Effect of androgenic and anabolic steroids on the sebaceous gland in power athletes. Acta Derm Venereol 67(1):36-40, 1987 93. Scott MJ 3rd, Scott AM: Effects of anabolic-androgenic steroids on the pilosebaceous unit. Cutis 50(2):113-116, 1992 94. Strauss RH, Liggett MT, Lanese RR: Anabolic steroid use and perceived effects in ten weighttrained women athletes. JAMA 253(19):2871-2873, 1985 95. Maravelias C et al: Adverse effects of anabolic steroids in athletes. A constant threat. Toxicol Lett 158(3):167-175, 2005 96. Evans NA. Current concepts in anabolic-androgenic steroids. Am J Sports Med 32(2):534-542, 2004 97. Scott MJ Jr, Scott MJ 3rd: Dermatologists and anabolic-androgenic drug abuse. Cutis 44(1):3035, 1989 98. Hartgens F, Kuipers H: Effects of androgenic-anabolic steroids in athletes. Sports Med 34(8):513554, 2004 99. Al-Ismail K et al: Gluteal mass in a bodybuilder: Radiological depiction of a complication of anabolic steroid use. Eur Radiol 12(6):1366-1369, 2002

107. Sarin CL, Austin JC, Nickel WO: Effects of smoking on digital blood-flow velocity. JAMA 229(10):1327-1328, 1974 108. Shepherd JT: Effect of cigarette-smoking on blood flow through the hand. Br Med J 2(4738):1007-1010, 1951 109. Benowitz NL et al: Interindividual variability in the metabolism and cardiovascular effects of nicotine in man. J Pharmacol Exp Ther 221(2):368-372, 1982 110. Aronow WS: Editorial: Smoking, carbon monoxide, and coronary heart disease. Circulation 48(6):1169-1172, 1973 111. Davis JW et al: Effects of tobacco and nontobacco cigarette smoking on endothelium and platelets. Clin Pharmacol Ther 37(5):529-533, 1985 112. Dintenfass L. Elevation of blood viscosity, aggregation of red cells, haematocrit values and fibrinogen levels with cigarette smokers. Med J Aust 1(20):617-620, 1975 113. Mikhailidis DP, et al: Cigarette smoking inhibits prostacyclin formation. Lancet 2(8350):627-628, 1983 114. Rees TD, Liverett DM, Guy CL: The effect of cigarette smoking on skin-flap survival in the face lift patient. Plast Reconstr Surg 73(6):911-915, 1984 115. Siana JE, Rex S, Gottrup F: The effect of cigarette smoking on wound healing. Scand J Plast Reconstr Surg Hand Surg 23(3):207-209, 1989 116. Hunt TK, Pai MP: The effect of varying ambient oxygen tensions on wound metabolism and collagen synthesis. Surg Gynecol Obstet 135(4):561567, 1972 117. Laurent P, Janoff A, Kagan HM: Cigarette smoke blocks cross-linking of elastin in vitro. Am Rev Respir Dis 127(2):189-192, 1983 118. Verghese A et al: The harlequin nail. A marker for smoking cessation. Chest 97(1):236-238, 1990 119. Saietz L: Prevalence of leukokeratosis nicotina palati among 3,819 danes. Community Dent Oral Epidemiol 3(2):80-85, 1975 120. Pindborg JJ et al: Frequency of Oral Carcinoma, Leukoplakia, Leukokeratosis, Leukoedema, Submucous Fibrosis, and Lichen Planus in 10,000 Indians in Lucknow, Uttar Pradesh, India; Preliminary Report. J Dent Res 44:61, 1965 121. Farman AG, Van Wyk CW: Leukokeratosis nicotina glossi-smokers tongue. Int J Oral Surg 6(6):340347, 1977

100. Weinreb I, Goldblum JR, Rubin BP: Factitial soft tissue pseudotumor due to injection of anabolic steroids: A report of 3 cases in 2 patients. Hum Pathol 41(3):452-455, 2010 101. Farkash U, Shabshin N, Pritsch Perry M: Rhabdomyolysis of the deltoid muscle in a bodybuilder using anabolic-androgenic steroids: A case report. J Athl Train 44(1):98-100, 2009 102. Syed SP et al: Anabolic steroids causing growth of benign tumors: Androgen receptor in angiolipomas. J Am Acad Dermatol 57(5):899-900, 2007 103. Lane PR et al: Acute hereditary coproporphyria induced by the androgenic/anabolic steroid methandrostenolone (Dianabol). J Am Acad Dermatol 30(2 Pt 2):308-312, 1994 104. Waeber B et al: Skin blood flow and cigarette smoking: The role of vasopressin. Clin Exp Hypertens A 6(10-11):2003-2006, 1984 105. Lefkowitz RJ: Editorial: Smoking, catecholamines, and the heart. N Engl J Med 295(11):615-616, 1976 106. Koch A et al: Acute cardiovascular reactions after cigarette smoking. Atherosclerosis 35(1):67-75, 1980

Copyright McGraw-Hill Companies, Inc. All rights reserved.

Chapter 105:

Cutaneous Manifestations of Drug Abuse

611

122. Axell T, Hedin CA: Epidemiologic study of excessive oral melanin pigmentation with special reference to the influence of tobacco habits. Scand J Dent Res 90(6):434-442, 1982 123. Mesa ML et al: Oral warty dyskeratoma. Cutis 33(3):293-294, 296, 1984 124. Winn DM: Smokeless tobacco and cancer: The epidemiologic evidence. CA Cancer J Clin 38(4):236-243, 1988 125. Gupta PC, Mehta FS, Pindborg JJ: Mortality among reverse chutta smokers in south India. Br Med J (Clin Res Ed) 289(6449):865-866, 1984 126. Gupta PC et al: Mortality experience in relation to tobacco chewing and smoking habits from a 10year follow-up study in Ernakulam District, Kerala. Int J Epidemiol 13(2):184-187, 1984 127. Christen AG: The impact of tobacco use and cessation on oral and dental diseases and conditions. Am J Med 93(1A):25S-31S, 1992 128. Wynder EL, Hoffmann D: Experimental tobacco carcinogenesis. Adv Cancer Res 8:249-453, 1964 129. Carmella SG et al: Mass spectrometric analysis of tobacco-specific nitrosamine hemoglobin adducts in snuff dippers, smokers, and nonsmokers. Cancer Res 50(17):5438-5445, 1990 130. Thomas WR, Holt PG, Keast D: Recovery of immune system after cigarette smoking. Nature 248(446):358-359, 1974 131. Holt PG, Thomas WR, Keast D: Smoking and immunity. Lancet 1(7815):1316, 1973 132. Hersey P, Prendergast D, Edwards A: Effects of cigarette smoking on the immune system. Follow-up studies in normal subjects after cessation of smoking. Med J Aust 2(9):425-429, 1983 133. Rigel DS et al: Cigarette smoking and malignant melanoma. Prognostic implications. J Dermatol Surg Oncol 7(11):889-891, 1981 134. Koh HK et al: Cigarette smoking and malignant melanoma. Prognostic implications. Cancer 53(11):2570-2573, 1984 135. Mills CM et al: Smoking habits in psoriasis: A case control study. Br J Dermatol 127(1):18-21, 1992 136. Naldi L et al: Family history, smoking habits, alcohol consumption and risk of psoriasis. Br J Dermatol 127(3):212-217, 1992 137. Transdermal nicotine for smoking cessation. Sixmonth results from two multicenter controlled clinical trials. Transdermal Nicotine Study Group. JAMA 266(22):3133-3138, 1991 138. Nakamura T: Tobacco dermatitis in Japanese harvesters. Contact Dermatitis 10(5):310, 1984

139. Goncalo M, Couto J, Goncalo S: Allergic contact dermatitis from Nicotiana tabacum. Contact Dermatitis 22(3):188-189, 1990 140. Singh G: Betel chewers perleche. Br J Dermatol 89(1):98, 1973 141. Zain RB et al: Oral mucosal lesions associated with betel quid, areca nut and tobacco chewing habits: Consensus from a workshop held in Kuala Lumpur, Malaysia, November 2527, 1996. J Oral Pathol Med 28(1):1-4, 1999 142. Daftary DK et al: An oral lichen planus-like lesion in Indian betel-tobacco chewers. Scand J Dent Res 88(3):244-249, 1980 143. Wei FC et al: Bilateral small radial forearm flaps for the reconstruction of buccal mucosa after surgical release of submucosal fibrosis: A new, reliable approach. Plast Reconstr Surg 107(7):1679-1683, 2001 144. Sankaranarayanan R et al: Risk factors for cancer of the buccal and labial mucosa in Kerala, southern India. J Epidemiol Community Health 44(4):286-292, 1990 145. Pindborg JJ et al: Oral submucous fibrosis as a precancerous condition. Scand J Dent Res 92(3):224-229, 1984 146. Pindborg JJ: Pathology of oral leukoplakia. Am J Dermatopathol 2(3):277-278, 1980 147. McGurk M, Craig GT: Oral submucous fibrosis: Two cases of malignant transformation in Asian immigrants to the United Kingdom. Br J Oral Maxillofac Surg 22(1):56-64, 1984 148. Su CC et al: Distinctive features of oral cancer in Changhua County: High incidence, buccal mucosa preponderance, and a close relation to betel quid chewing habit. J Formos Med Assoc 106(3):225-233, 2007 149. Bergstein JM et al: Soft tissue abscesses associated with parenteral drug abuse: Presentation, microbiology, and treatment. Am Surg 61(12):11051108, 1995 150. Gonzalez MH et al: Abscesses of the upper extremity from drug abuse by injection. J Hand Surg Am 18(5):868-870, 1993 151. Smith DJ Jr et al: Drug injection injuries of the upper extremity. Ann Plast Surg 22(1):19-24, 1989 152. Vollum DI: Skin lesions in drug addicts. Br Med J 2(5710):647-650, 1970 153. Funk L, Grover D, de Silva H: Compartment syndrome of the hand following intra-arterial injection of heroin. J Hand Surg Br 24(3):366-367, 1999

Copyright McGraw-Hill Companies, Inc. All rights reserved.

612

Chapter 105:

Cutaneous Manifestations of Drug Abuse

154. Klabacha ME et al: Inadvertent intraradial arterial injection of cocaine. Ann Plast Surg 13(1):60-62, 1984 155. Pieper B, Templin T: Chronic venous insufficiency in persons with a history of injection drug use. Res Nurs Health 24(5):423-432, 2001 156. Pieper B: A retrospective analysis of venous ulcer healing in current and former users of injected drugs. J Wound Ostomy Continence Nurs 23(6):291-296, 1996 157. Burris S et al: Physician prescribing of sterile injection equipment to prevent HIV infection: Time for action. Ann Intern Med 133(3):218-226, 2000 158. Administration USSAaMHS: Number of Emergency Department Visits Associated with Various Drugs in 2001, 2001, http://thedea.org/statistics.html, accessed Apr 15, 2010 159. Policy OONDC: http://www.whitehousedrugpolicy.gov, accessed Jun 1, 2010 160. Labcorp I: Drugs of Abuse Reference Guide, 2004, https://www.labcorp.com/pdf/doa_reference_ guide.pdf, accessed May 1, 2010

Copyright McGraw-Hill Companies, Inc. All rights reserved.